APGE Apogee Therapeutics
- 53.530
- -2.700-4.80%
- 53.530
- 0.0000.00%
Apogee Therapeutics News
Apogee Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Dambkowski Carl
Apogee Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer HENDERSON MICHAEL THOMAS
Apogee Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Wellington Management Group LLP(10.70%),Wellington Group Holdings LLP(10.70%), etc.
Apogee Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Dambkowski Carl
Apogee Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer HENDERSON MICHAEL THOMAS
Apogee Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Henderson Jane
Apogee Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Dambkowski Carl
Apogee Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer HENDERSON MICHAEL THOMAS
Apogee Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer HENDERSON MICHAEL THOMAS
Apogee Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Dambkowski Carl
Apogee Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director JONES WILLIAM A JR
Apogee Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director McKenna Mark C.
Apogee Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Bollinger Lisa
Apogee Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Fox Jennifer A.
Apogee Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Shah Nimish P
Apogee Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Gottesdiener Andrew
Apogee Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Fairmount Funds Management LLC
Apogee Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Bollinger Lisa
Apogee Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Bollinger Lisa
Apogee Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Fairmount Funds Management LLC
Analysis
Price Target
No Data
No Data